Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Hi, it's Amber in Hong Kong. Blockbuster weight-loss drug Wegovy is going to be much cheaper in China than it is in the US.

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

Ozempic is approved only for treating Type 2 diabetes but claims about its weight-loss powers have seen demand soar, ...

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...

Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...

There’s no hard-and-fast rule for how long it’s safe to stay on Ozempic for weight loss. Novo Nordisk-sponsored studies lasting up to two years show that semaglutide is safe.

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...